Mountcastle David sold $17K of PRVA
Mountcastle David (EVP & Chief Financial Officer) sold 600 shares of Privia Health Group, Inc. (PRVA) at $27.57 on 2026-07-07 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the record of insider activity but does not introduce new operational or financial catalysts.
Market read
Routine officer selling under a pre-arranged 10b5-1 plan, with limited expected impact on valuation.
What to watch
Traders may check whether the sale size is part of a larger scheduled program, but this brief only discloses the single transaction.
Background
This is an SEC Form 4 insider transaction for Privia Health Group, Inc., reported by the CFO.
Ticker impact
Privia CFO David Mountcastle sold 600 shares in an open-market transaction at $27.57 on 2026-07-07 under a 10b5-1 plan.
Low likelihood of a sustained price move solely from this Form 4 sale.
The filing is a small, pre-arranged 10b5-1 open-market sale by an officer, with no accompanying guidance, deal, or regulatory event disclosed.
Market effects
No clear read-across to healthcare services or managed care; this is company-specific insider activity.
None.
None.
Counterpoint
Even 10b5-1 sales can coincide with private information, but the article provides no new qualitative context beyond the pre-arranged plan.
Key entities
- issuerPrivia Health Group, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderDavid Mountcastle
EVP and Chief Financial Officer who sold shares under a 10b5-1 plan.
